Bio-Rad Q4 Revenues Climb 4 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – Bio-Rad Laboratories said after the close of the market on Tuesday that fourth-quarter revenues improved 4 percent year over year as the firm beat the average analyst estimate on the top and bottom lines.

The company took in $573.8 million in revenues for the three months ended Dec. 31, 2012, up from $550.2 million a year ago, easily surpassing the average analyst estimate of $558.7 million.

On a currency-neutral basis, revenues were up 6 percent year over year, Bio-Rad said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.